| PRIMARY INFORMATION |
|---|
| ID | 1247 |
| PMID | 10205635 |
| Year | 1999 |
| Sequence | pGlu-HP |
| Name | Thyrotropin-releasing hormone (TRH) |
| Length | 3 |
| N-Terminal Modification | Free |
| C-Terminal Modification | Amidation |
| Linear/ Cyclic | Cyclic |
| Chirality | L |
| Chemical Modification | pGlu= Pyroglutamic acid |
| Origin of Peptide | Synthetic |
| Nature of Peptide/Cargo | It is a tripeptide that used in the treatment of brain and spinal cord injury and certain CNS disorders, including Alzheimer’s disease and motor neuron disease (MND) |
| Mechanism | Not mentioned |
| Cargo Sequence/Structure | None |
Name of cargo
| Not applicable |
| Assay | Radioimmunoassay and Liquid Scintillation Technique |
| Enhancer | Cineole and Ethanol |
| Properties of enhancer | The enhancement factors are driving force for permeation is the thermodynamic activity of the permeant in the donor solution. |
| Concentration | TRH in PBS (under control conditions) |
| Incubation time | 30 h |
| Tissue permeability (value with units) | Permeability coefficient (Kp)= 5.4*105 cm/h, Cumulative amount= 7.8± 1.7 µg/cm2, Enhancement factor (EF) =0 |
| Tissue Sample | Human epidermal membrane |
| Ex vivo/In vivo/In vitro | in vitro |
| SECONDARY INFORMATION |
|---|
| STRUCTURE | |
| SMILES | N.A. |
